Applied Health Economics and Health Policy

, Volume 14, Issue 3, pp 349–359 | Cite as

The Role of Physician Recommendations and Public Policy in Human Papillomavirus Vaccinations

Original Research Article

Abstract

Background

Immunization rates for human papillomavirus (HPV) infections remain low among teenagers despite strong evidence of the effectiveness of vaccines. Physician recommendations of the vaccine are far from universal. Several states have enacted policies that mandate HPV vaccination or distribute educational materials.

Objectives

To provide policy makers, physicians, and researchers information on the relative importance of physician recommendations and early state-level policies to promote HPV vaccinations among targeted age groups.

Methods

We first use probit models to determine the strongest correlates of immunization in a nationally representative US sample of teenagers. We then use instrumental variable probit models to determine the direct role that physician recommendations play in vaccination using plausibly exogenous physician encounters that are likely not the result of more health-conscious parents seeking out information on the vaccine.

Results

We show that children in the targeted age range who are more likely to encounter physicians for reasons other than seeking out the vaccine, such as through mandatory wellness exams or previous asthma diagnoses, are significantly more likely to get the vaccine. There is no consistent evidence that the state policies we analyze have been effective.

Conclusion

Encouraging recommendations by physicians may be the most effective path toward increasing HPV vaccination. State-level mandates and policies are yet to exhibit effectiveness.

Supplementary material

40258_2016_225_MOESM1_ESM.docx (43 kb)
Supplementary material 1 (DOCX 42 kb)

References

  1. 1.
    Center for Disease Control and Prevention. Human papillomavirus (HPV). 2014. http://www.cdc.gov/std/hpv/. Accessed 1 Dec 2015.
  2. 2.
    Center for Disease Control and Prevention. Vaccine safety, human papillomavirus (HPV) vaccine. 2014. http://www.cdc.gov/vaccinesafety/vaccines/HPV/index.html. Accessed 1 Dec 2015.
  3. 3.
    Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, Babbel C, Kempe A. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics. 2010;126(3):425–33.CrossRefPubMedGoogle Scholar
  4. 4.
    Jain N, Euler GL, Shefer A, Lu P, Yankey D, Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Prev Med. 2009;48(5):426–31.CrossRefPubMedGoogle Scholar
  5. 5.
    Black LL, Zimet GD, Short MB, Sturm L, Rosenthal SL. Literature review of human papillomavirus vaccine acceptability among women over 26 years. Vaccine. 2009;27(11):1668–73.CrossRefPubMedGoogle Scholar
  6. 6.
    Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45:107–14.CrossRefPubMedGoogle Scholar
  7. 7.
    Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168(1):76–82.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Colgrove J, Abiola S, Mello MM. HPV vaccination mandates-lawmaking amid political and scientific controversy. N Engl J Med. 2010;363(8):785–91.CrossRefPubMedGoogle Scholar
  9. 9.
    Bugenske E, Stokley S, Kennedy A, Dorell C. Middle school vaccination requirements and adolescent vaccination coverage. Pediatrics. 2012;129(6):1056–63.CrossRefPubMedGoogle Scholar
  10. 10.
    Kenkel DS, Terza JV. The effect of physician advice on alcohol consumption: count regression with an endogenous treatment effect. J Appl Econom. 2001;16(2):165–84.CrossRefGoogle Scholar
  11. 11.
    Kreuter MW, Chheda SG, Bull FC. How does physician advice influence patient behavior? evidence for priming effect. Arch Fam Med. 2000;9(5):426–33.CrossRefPubMedGoogle Scholar
  12. 12.
    Maurer J, Harris KM, Uscher-Pines L. Can routine offering of influenza vaccination in office-based settings reduce racial and ethnic disparities in adult influenza vaccination? J Gen Intern Med. 2014;29(12):1624–30.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Maurer J, Harris KM. Issuance of patient reminders for influenza vaccination by US-based primary care physicians during the first year of universal influenza vaccination recommendations. Am J Public Health. 2014;104(6):e60–2.CrossRefPubMedGoogle Scholar
  14. 14.
    Nowak GJ, Sheedy K, Bursey K, Smith TM, Basket M. Promoting influenza vaccination: insights from a qualitative meta-analysis of 14 years of influenza-related communications research by US Centers for Disease Control and Prevention (CDC). Vaccine. 2015;33(24):2741–56.CrossRefPubMedGoogle Scholar
  15. 15.
    Szilagyi PG, Rand CM, McLaurin J, Tan L, Britto M, Francis A, Rickert D. Delivering adolescent vaccinations in the medical home: a new era? Pediatrics. 2008;121(Supplement 1):S15–24.CrossRefPubMedGoogle Scholar
  16. 16.
    Ylitalo KR, Lee H, Mehta NK. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health. 2013;103(1):164–9.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD. Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician’s recommendation. Vaccine. 2011;29(5):890–5.CrossRefPubMedGoogle Scholar
  18. 18.
    Do YK, Wong KY. Awareness and acceptability of human papillomavirus vaccine: an application of the instrumental variables bivariate probit model. BMC Public Health. 2012;12(1):31.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Laz TH, Rahman M, Berenson AB. An update on human papillomavirus vaccine uptake among 11–17 Year old girls in the United States: National Health Interview Survey, 2010. Vaccine. 2012;30(24):3534–40.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    National Conference of State Legislatures. Immunization policy issues overview. 2011. http://www.ncsl.org/research/health/immunizations-policy-issues-overview.aspx. Accessed 1 Dec 2015.
  21. 21.
    Rosenbaum S, Stewart A, Cox M, Mitchell M. The epidemiology of US. Immunization law: mandated coverage of immunization under State Health Insurance Laws. Report from Center for Health Service and Research Policy. 2003.Google Scholar
  22. 22.
    Currie J, Gruber J. Health insurance eligibility, utilization of medical care, and child health. Q J Econ. 1996;111(2):431–66.CrossRefGoogle Scholar
  23. 23.
    Decker SL. In 2011 nearly one-third of physicians said they would not accept new medicaid patients, but rising fees may help. Health Affairs (Project Hope). 2012;31(8):1673–9.CrossRefGoogle Scholar
  24. 24.
    Tomljenovic L, Shaw CA. Too fast or not too fast: the FDA’s approval of Merck’s HPV vaccine Gardasil. J Law Med Ethics J Am Soc Law Med Ethics. 2012;40(3):673–81.Google Scholar
  25. 25.
    Akinbami LJ, Moorman JE, Liu X, National Center for Health Statistics (US). Asthma prevalence, health care use, and mortality: United States, 2005–2009. Hyattsville, MD: US Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2011.Google Scholar
  26. 26.
    Bloom B, Jones LI, Freeman G. Summary health statistics for US children: National Health Interview Survey, 2012. National Center for Health Statistics. Vital Health Stat. 2013;10(258):4–8.Google Scholar
  27. 27.
    Bednarczyk A, Birkhead GS, Morse DL, Doleyres H. Human papillomavirus vaccine uptake and barrier, actual risk and race/ethnicity among female student at a New York State University, 2010. Vaccine. 2011;29:3138–43.CrossRefPubMedGoogle Scholar
  28. 28.
    Barrett S. Economic considerations for the eradication endgame. Philos Trans R Soc B Biol Sci. 2013;368(1623):20120149.CrossRefGoogle Scholar
  29. 29.
    Anikeeva O, Braunack-Mayer A, Rogers W. Requiring influenza vaccination for health care workers. Am J Public Health. 2009;99(1):24.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    May T. Public communication, risk perception, and the viability of preventive vaccination against communicable diseases. Bioethics. 2005;19(4):407–21.CrossRefPubMedGoogle Scholar
  31. 31.
    Maurer J. Who has a clue to preventing the flu? Unravelling supply and demand effects on the take-up of influenza vaccinations. J Health Econ. 2009;28(3):704–17.CrossRefPubMedGoogle Scholar
  32. 32.
    Hamlish T, Clarke L, Alexander KA. Barriers to HPV immunization for African American adolescent females. Vaccine. 2012;30(45):6472–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Gamble HL, Klosky JL, Parra GR, Randolph ME. Factors influencing familial decision-making regarding human papillomavirus vaccination. J Pediatr Psychol. 2010;35(7):704–15.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Neubrand TP, Breitkopf CR, Rupp R, Breitkopf D, Rosenthal SL. Factors associated with completion of the human papillomavirus vaccine series. Clin Pediatr. 2009;48(9):966–9.CrossRefGoogle Scholar
  35. 35.
    Hebert PL, Frick KD, Kane RL, McBean AM. The causes of racial and ethnic differences in influenza vaccination rates among elderly medicare beneficiaries. Blackwell Science Inc. 2005. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1361154. Accessed 1 Dec 2015.
  36. 36.
    Gelman A, Miller E, Schwarz EB, Akers AY, Jeong K, Borrero S. Racial disparities in human papillomavirus vaccination: does access matter?”. J Adolesc Health Off Publ Soc Adolesc Med. 2013;53(6):756–62.CrossRefGoogle Scholar
  37. 37.
    Niccolai LM, Mehta NR, Hadler JL. Racial/Ethnic and poverty disparities in human papillomavirus vaccination completion. Am J Prev Med. 2011;41(4):428–33.CrossRefPubMedGoogle Scholar
  38. 38.
    Reiter PL, Noel T, Brewer SL, Gottlieb AM, Smith JS. Parents’ health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med. 2009;69(3):475–80.CrossRefPubMedGoogle Scholar
  39. 39.
    Saslow D, Castle PE, Cox JT, Davey DD, Einstein MH, Ferris DG, Goldie SJ, Gynecologic Cancer Advisory Group. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin. 2007;57(1):7–28.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.School of Medicine and Health ScienceGeorge Washington UniversityWashingtonUSA
  2. 2.Department of EconomicsUniversity of Wisconsin-MilwaukeeMilwaukeeUSA

Personalised recommendations